Suppr超能文献

用于开发第三代疫苗的无抗生素抗性的哺乳动物表达质粒载体pPAL

The antibiotic resistance-free mammalian expression plasmid vector pPAL for development of third generation vaccines.

作者信息

Alcolea Pedro J, Alonso Ana, Larraga Vicente

机构信息

Laboratory of Molecular Parasitology, Department of Cellular and Molecular Biology, Centro de Investigaciones Biológicas (Consejo Superior de Investigaciones Científicas). Calle Ramiro de Maeztu, 9, 28040 Madrid, Spain.

出版信息

Plasmid. 2019 Jan;101:35-42. doi: 10.1016/j.plasmid.2018.12.002. Epub 2018 Dec 6.

Abstract

DNA vaccines require a vector to replicate genes and express encoding antigens. Antibiotic resistance genes are often used as selection markers, which must not be released to the environment upon final product commercialization. For this reason, generation of antibiotic resistance-free vectors is imperative. The pPAL vector contains the cytomegalovirus enhancer and promoter for expression in mammalian cells and the E. coli fabI chromosomal gene as a selectable marker. The fabI gene encodes the enoyl-ACP reductase (FabI). The bacteriostatic compound triclosan is an inhibitor of this enzyme. Therefore, the selection of positive clones depends on the enzyme:inhibitor molar ratio. According to western blot analysis, the pPAL vector is functional for expression of the Leishmania infantum (Kinetoplastid: Trypanosomatidae) gene encoding for the protein kinase C receptor analog (LACK/p36) in the HEK293T human cell line transfected with pPAL-LACK. The fabI gene sequence contains a 210 bp CpG island, suggesting a potential role as an adjuvant of the antibiotic resistance-free pPAL vector. In fact, Th1 response induction levels against canine leishmaniasis only using pPAL-LACK was shown to be as strong as in previous strategies using a recombinant vaccinia virus in combination with standard mammalian expression plasmid vectors. In summary, the pPAL plasmid contains the essential elements for manipulation and expression of any cloned DNA sequence in prokaryotic and mammalian cells using an E. coli endogenous gene as a selectable marker, which also provides a long CpG island. This element enhances Th1 immune response against L. infantum infection in dogs using the gene encoding for the LACK antigen. Therefore, this antibiotic resistance-free plasmid is a vaccine vector actively participating in protection against canine leishmaniasis and may be potentially tested as a vaccine vector with other antigens against different pathogens.

摘要

DNA疫苗需要一种载体来复制基因并表达编码抗原。抗生素抗性基因常被用作选择标记,在最终产品商业化时这些基因绝不能释放到环境中。因此,生成无抗生素抗性的载体势在必行。pPAL载体包含用于在哺乳动物细胞中表达的巨细胞病毒增强子和启动子,以及作为选择标记的大肠杆菌fabI染色体基因。fabI基因编码烯酰-ACP还原酶(FabI)。抑菌化合物三氯生是这种酶的抑制剂。因此,阳性克隆的选择取决于酶与抑制剂的摩尔比。根据蛋白质印迹分析,在转染了pPAL-LACK的HEK293T人细胞系中,pPAL载体对于编码蛋白激酶C受体类似物(LACK/p36)的婴儿利什曼原虫(动质体:锥虫科)基因的表达具有功能活性。fabI基因序列包含一个210 bp的CpG岛,这表明无抗生素抗性的pPAL载体具有作为佐剂的潜在作用。事实上,仅使用pPAL-LACK诱导的针对犬利什曼病的Th1反应水平已被证明与先前使用重组痘苗病毒联合标准哺乳动物表达质粒载体的策略一样强。总之,pPAL质粒包含使用大肠杆菌内源基因作为选择标记在原核细胞和哺乳动物细胞中操作和表达任何克隆DNA序列的基本元件,该基因还提供一个长的CpG岛。这个元件利用编码LACK抗原的基因增强了针对犬类婴儿利什曼原虫感染的Th1免疫反应。因此,这种无抗生素抗性的质粒是一种积极参与预防犬利什曼病的疫苗载体,并且可能作为针对不同病原体的其他抗原的疫苗载体进行潜在测试。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验